Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

208
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
208
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

324
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
324
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

437
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
437
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

310
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
310
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The association between chronic rhinosinusitis, bronchiectasis and type 2 inflammation: an EMBARC registry analysis.

ERJ open research·2026
Same author

Impact of a follow-up visit on two-year mortality after severe exacerbation of COPD in Finland.

European clinical respiratory journal·2026
Same author

From mild-to-moderate to severe asthma: Risk factors and patient profiles from the NORDSTAR cohort.

American journal of respiratory and critical care medicine·2026
Same author

Narrative review: mucus plugging in chronic obstructive lung diseases and bronchiectasis.

European clinical respiratory journal·2026
Same author

Association Between Obesity and Sex-Related Survival Difference in Lung Cancer.

JCO clinical cancer informatics·2026
Same author

Identifying an At-Risk Asthma Phenotype: Allergy and Recurrent Infections Predict Severe Disease.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026

Related Experiment Video

Updated: Sep 11, 2025

Bronchoalveolar Lavage BAL for Research; Obtaining Adequate Sample Yield
11:47

Bronchoalveolar Lavage BAL for Research; Obtaining Adequate Sample Yield

Published on: March 24, 2014

74.0K

Risk factors for mortality in Finnish bronchiectasis patients: A four-year study.

Jarkko Mäntylä1, Witold Mazur1, Tanja Törölä2

  • 1Department of Respiratory Diseases, Heart and Lung Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Chronic Respiratory Disease
|August 18, 2025
PubMed
Summary

In non-cystic fibrosis bronchiectasis patients, higher FACED, E-FACED, and modified Medical Research Council (mMRC) scores predict mortality risk. Lower quality of life scores also indicate increased mortality risk in bronchiectasis patients.

Keywords:
bronchiectasismortalityquality of life

More Related Videos

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

1.0K
Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells
09:15

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells

Published on: May 11, 2020

6.1K

Related Experiment Videos

Last Updated: Sep 11, 2025

Bronchoalveolar Lavage BAL for Research; Obtaining Adequate Sample Yield
11:47

Bronchoalveolar Lavage BAL for Research; Obtaining Adequate Sample Yield

Published on: March 24, 2014

74.0K
Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

1.0K
Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells
09:15

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells

Published on: May 11, 2020

6.1K

Area of Science:

  • Pulmonology
  • Respiratory Medicine
  • Clinical Epidemiology

Background:

  • Non-cystic fibrosis bronchiectasis (BE) is a chronic respiratory condition.
  • Identifying mortality risk factors in BE patients is crucial for prognosis and management.

Purpose of the Study:

  • To identify risk factors for all-cause mortality in adult non-cystic fibrosis bronchiectasis patients within a Finnish cohort.
  • To evaluate the predictive value of established scoring systems and patient-reported outcomes.

Main Methods:

  • A 4-year prospective follow-up study of 95 adult non-cystic fibrosis bronchiectasis patients.
  • Data collected included medical records, Quality of Life-Bronchiectasis (QoL-B) questionnaire, Bronchiectasis Severity Index (BSI), FACED score, E-FACED score, and modified Medical Research Council (mMRC) dyspnoea scale.
  • Cox's regression analysis was employed to assess mortality predictors.

Main Results:

  • Eight patients (8.4%) died during the follow-up period.
  • Increased risk of mortality was associated with higher FACED (HR 1.9), E-FACED (HR 1.5), and mMRC (HR 3.2) scores.
  • Lower scores in physical, vitality, respiration, and health domains of the QoL-B were significantly associated with mortality.

Conclusions:

  • Multifactorial scores like FACED and BSI, along with the mMRC dyspnoea scale, are significant predictors of mortality in non-cystic fibrosis bronchiectasis.
  • The mMRC scale offers a simple yet valuable tool for clinical risk assessment in these patients.